Site Terms of Use

Noncommercial Use of Site Documents, Respecting All Trademarks

Biogen Idec hereby authorizes you to copy documents published by Biogen Idec on the World Wide Web for non-commercial use only, provided any copy of these documents which you make retains all copyright and other proprietary notices contained therein. You should assume that all contents of TYSABRI.com (the "Site") are copyrighted unless otherwise noted and may not be used except as provided herein and with the express written permission of Biogen Idec.

All product names, logos, and service marks displayed on the Site identified by ® or ™ or appearing in type form different from that of the surrounding text (collectively, the "Trademarks") are registered or unregistered trademarks owned by or licensed to Biogen Idec or its affiliates, unless otherwise identified as being owned by another entity. TOUCH, TYSABRI and associated logos are registered trademarks of Biogen Idec. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right, either express or implied, under any patent or Trademark of Biogen Idec or any third party. No use of any Trademark may be made without the prior written authorization of Biogen Idec, except to identify the product or services of the company.

Images of people or places displayed on the Site are either the property of, or used with permission by, Biogen Idec. The use of these images by you is prohibited unless specifically permitted by this Legal Disclaimer or by specific permission provided elsewhere on the Site. Unauthorized use of the images may violate copyright, trademark, privacy and/or publicity laws as well as communications regulations and statutes.

Information Intended for U.S. Residents Only

All Biogen Idec products, materials and information appearing on this site are intended for US residents only.

Special Notice to Healthcare Professionals

The information appearing on this Site is intended for health care professionals licensed and practicing in the United States. The product usage descriptions and educational information contained on this Site are intended for a health care professional audience. To the best knowledge of Biogen Idec, the information provided represents the scientifically supported current product information. Please refer to the specific product package insert/prescribing information for instructions and information before prescribing, recommending or administering any medication. All such product information should be interpreted by, and the product used only under the supervision of, a physician or other qualified health professional.

BY USING THIS SITE YOU ACKNOWLEDGE THAT BIOGEN IDEC IS PROVIDING THE MATERIAL CONTAINED IN THE SITE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. THIS INFORMATION IS NOT INTENDED FOR THE PURPOSE OF PROVIDING YOU WITH MEDICAL ADVICE. YOU SHOULD NOT RELY ON THE MATERIALS CONTAINED IN THIS SITE IN DECIDING ON A TREATMENT PLAN, DRUG USAGE, OR IN MAKING ANY OTHER MEDICAL DECISIONS IN THE TREATMENT OF YOUR PATIENTS. INSTEAD, YOU SHOULD RELY ON YOUR OWN PROFESSIONAL AND MEDICAL JUDGMENT IN ALL TREATMENT DECISIONS AND ON YOUR KNOWLEDGE OF THE PARTICULAR PATIENT.

Information Is No Substitute for Consulting a Health Professional

The information on the Site is intended only to provide knowledge of multiple sclerosis health topics. This information should not be considered complete and should not be used in place of a visit, call, consultation or advice of a physician or other health care provider. Biogen Idec does not recommend the self-management of health problems. Information obtained by using the Site is not exhaustive and does not cover all ailments, physical conditions or their treatment. Should you have any health care-related questions, please call or see your physician or other health care provider promptly. You should never disregard medical advice or delay in seeking it because of something you have read here.

Information Is Not Necessarily Accurate, Complete, or Current

Information accessed on the Site is not exhaustive. Biogen Idec makes reasonable efforts to include accurate and current information, wherever possible, but makes no warranties or representations as to its accuracy or completeness. This information is provided "as is" without warranty of any kind, either express or implied, including but not limited to implied warranty of fitness for a particular purpose.

Biogen Idec Is Not Responsible For Computer Damage Resulting From Using the Site

Biogen Idec makes no representation or warranty that access to the Site will be available on a timely basis, will be uninterrupted or will be error free. Biogen Idec does not warrant that these pages, or the server that makes them available, are free of viruses or other harmful elements. In no event shall any of Biogen Idec, its affiliates and subsidiaries, and their respective officers, directors, employees, agents, representatives, information providers and licensors and their respective heirs and assigns, be liable for any direct, indirect, incidental, consequential, exemplary, special, punitive or other damages even if informed of the possibility of such damages. The above exclusion may not apply in jurisdictions to the extent that they do not allow the exclusion of implied warranties.

Biogen Idec Does Not Endorse the Content of Linked External Sites

The Site links you to other sites on the Internet which we believe may offer useful information. However, Biogen Idec has not reviewed all of the sites that may be linked to the Site and is not responsible for the content of any pages off the Site. Your linking to any other pages on other sites is at your own risk. Please remember that such sites are not Biogen Idec sites and the content on such sites could change without Biogen Idec's knowledge. The opinions, claims, comments, or software contained in hyperlinked sites are those of the companies responsible for such sites and should not be attributed to Biogen Idec. Biogen Idec has not attempted to verify the truth or accuracy of any such opinion, claim or comment, nor do we endorse or support them. Biogen Idec does not warrant, nor is it in any way responsible for, software on hyperlinked sites that are outside of Biogen Idec's control.

Governing Laws

Your use of this Site is governed by the laws of the Commonwealth of Massachusetts, without resort to its conflicts of law principles. If any provisions of this Legal Disclaimer are found to be invalid or unenforceable by any court of competent jurisdiction, the invalidity or unenforceability of such provisions shall not affect the validity or enforceability of any of the remaining provisions of this Legal Disclaimer.

You expressly agree that exclusive jurisdiction for any dispute with Biogen Idec or any of its affiliates in any way relating to your use of this Site shall be exclusively in the Federal or state courts of the Commonwealth of Massachusetts. Any claim(s) arising in connection with your use of this web site, or any of its content, must be brought within one (1) year of the date that the event giving rise to such claim(s) occurred.

Entire Agreement

Except as expressly provided on this Site, or as set forth in this Legal Disclaimer or the Privacy Policy, this Legal Disclaimer constitutes the entire agreement between you and Biogen Idec and its affiliates with respect to the use of this Site and its content, including any information provided by you on this Site.

Assenting to Legal Disclaimer and Changes

Biogen Idec reserves the right to make additions, deletions, or modifications to the information or materials on the Site at any time without any prior notification, including to this Legal Disclaimer. You are bound by any such revisions and should, therefore, periodically visit this page to review the current Legal Disclaimer.

By using this Site, you are assenting to the terms contained in this Legal Disclaimer and any posted changes to the Legal Disclaimer.

Effective Date: January 4, 2011

Indication
TYSABRI is indicated as monotherapy for the treatment
of patients with relapsing
forms of multiple sclerosis to delay the accumulation of physical disability and reduce
the frequency of clinical exacerbations. The efficacy of TYSABRI beyond 2 years is unknown. Because TYSABRI increases the risk of progressive multifocal leukoencephalopathy (PML), an opportunistic viral infection of the brain that usually leads to death or severe disability, TYSABRI is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate multiple sclerosis therapy. Safety and efficacy in patients with chronic progressive multiple sclerosis have not been studied.

You are leaving this site. This link will take you to a website that is outside the control of Biogen Idec. We provide links as a public service and for informational purposes only. We do not make or imply any endorsement of external web sites.

Click Cancel to return or OK to continue.

  

You have clicked on a link that will take you out of this website.

Click Cancel to return or OK to continue.

  

Blank Overlay Used To Show Alert Messages Automatically

Submission Is In Progress
One Moment Please.

Accepting outside referrals indicates an infusion site is willing to accept patients outside of their current practice. If they do not accept outside referrals then they only accept patients who are part of their current practice.

THANK YOU FOR REGISTERING!

We look forward to sharing exclusive information and updates about TYSABRI.

THANK YOU

Your profile is updated.